KRAS and cholangiocarcinoma: Genetically, the pathogenesis of CCA is complex and involved in dysregulation of numerous oncogenic drivers and tumor suppressors such as VEGF, BRAF, TP53, KRAS, SMAD4, IDH1/2, FGFR, BAP1, and MCL16–12.